Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.

Prenatal diagnosis - 1 Mar 2008

Li Ying, Finning Kirstin, Daniels Geoff, Hahn Sinuhe, Zhong Xiaoyan, Holzgreve Wolfgang

Abstract excerpt

BACKGROUND: Alloimmunization against the fetal Kell (KEL1) blood group antigen is gaining importance relative to the Rhesus problem and is the second most important cause of hemolytic disease of the fetus and newborn. Molecular diagnosis for fetal KEL1, which currently involves invasive procedures, is routinely done for accessing whether a fetus is at risk. Here we developed a matrix-assisted laser...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA
Share to Fetal Blood
Share to Kell Blood-Group System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Spectrometry

Share to Pregnancy

Share to Pregnancy Trimester, Second

Share to Pregnancy Trimester, Third

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 18241084
DOI: 10.1002/pd.1936

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Noninvasive genotyping fetal Kell blood group (KEL1) using cell-free fetal DNA in maternal plasma by MALDI-TOF mass spectrometry.PMID 18241084Read ↗

Next-generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell-free fetal DNA in maternal plasma.Semantic proximity Read ↗

An innovative test for non-invasive Kell genotyping on circulating fetal DNA by means of the allelic discrimination of K1 and K2 antigens.Semantic proximity Read ↗

Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols.Semantic proximity Read ↗

Next-Generation Sequencing for Antenatal Prediction of KEL1 Blood Group Status.Semantic proximity Read ↗

Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers.Semantic proximity Read ↗

Non-invasive fetal ABO genotyping in maternal plasma using real-time PCR.Semantic proximity Read ↗

Noninvasive Antenatal Determination of Fetal Blood Group Using Next-Generation Sequencing.Semantic proximity Read ↗

Recent developments in fetal nucleic acids in maternal plasma: implications to noninvasive prenatal fetal blood group genotyping.Semantic proximity Read ↗

Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping--the alternative approach.Semantic proximity Read ↗

Recent advances in non-invasive fetal HPA-1a typingSemantic proximity Read ↗

Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.Semantic proximity Read ↗

Use of maternal plasma for non-invasive prenatal diagnosis of fetal ABO genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.